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Introduction: As part of a reconsideration of coverage policy, the Centers for Medicare and Medicaid Services requested
a systematic review of the evidence on the use of pneumatic compression devices in the home environment for treatment
of chronic venous insufficiency (CVI) and venous ulcers.
Methods: Articles were found with a systematic literature search of MEDLINE, EMBASE, and AMED (Allied and
Complementary Medicine) databases, hand searches of reference lists, and suggestions of experts.
Results: Eight trials that met the inclusion criteria, including several randomized control trials, were found. Most studies
were small and may have been underpowered. However, several were well-designed randomized controlled trials. Three
studies showed that the devices could alleviate symptoms of CVI. No studies directly measured whether the devices could
prevent the occurrence of venous ulcers. Some studies on the treatment of venous ulcers did not show a benefit for
pneumatic compression, but other studies showed a benefit for the devices in healing long-standing chronic ulcers that
had not healed with other methods. No studies directly compared single-chamber and multiple-chamber devices or
studied whether the effectiveness of the pump was dependent on types of treatment used concurrently with the pump.
Few adverse events were reported in the trials. Patients generally expressed satisfaction with the pneumatic compression
devices, and several studies reported higher compliance than with other compression methods.
Conclusion: The available data cannot be relied on to inform the optimal choice of compression therapy or optimal
protocol for patients with CVI or venous ulcers. Methodologically rigorous research designed to answer these questions
would be useful for treatment decisions. The Centers for Medicare and Medicaid Services considered the results of this
study and issued a decision that pneumatic compression will only be covered for patients with refractory edema with
significant ulceration of the lower extremities after a 6-month trial of standard therapies, such as compression stockings,
has failed. (J Vasc Surg 2003;37:539-44.)
The Centers for Medicare and Medicaid Services
(CMS; formerly the Health Care Financing Administra-
tion) requested a technology assessment on the use of
pneumatic compression devices for the treatment of venous
insufficiency and chronic ulcers. This manuscript is based
on the technology assessment/systematic review that was
submitted to CMS.
At the time of the request, CMS was reconsidering its
coverage policy; the policy was to cover pneumatic com-
pression devices for patients with refractory edema with
significant ulceration of the lower extremities with failure to
heal after 6 months of treatment with other methods, such
as compression bandages. CMS requested that the Agency
for Healthcare Research and Quality find and evaluate
evidence related to the use of intermittent pneumatic com-
pression devices for the treatment of venous insufficiency
and leg ulcers in the home.
BACKGROUND
Chronic venous insufficiency (CVI) of the lower ex-
tremities is a condition caused by abnormalities of the
venous wall and valves that leads to obstruction or reflux of
blood flow in the veins.1 Symptoms and signs of CVI
include hyperpigmentation, stasis dermatitis, chronic
edema, and venous ulcers. Severe and persistent edema
leads to secondary lymphedema and trapped fluid. The calf
becomes permanently enlarged and hard, and ulcers occur
more frequently and are more difficult to heal.2
Approximately 3% to 11% of the adult population has
skin changes and edema from CVI.1 Studies of the preva-
lence of venous leg ulcers found that venous ulcers occur in
approximately 0.18% to 1.3% of the adult population, with
only 50% with healing by 4 months, 20% with open ulcers at
2 years, and 8% with open ulcers at 5 years.1
Wide consensus exists in the literature that compression
is a necessary part of all treatments for CVI and venous
ulcers. A list of reviews and guidelines related to the use of
compression is given in Appendix 1 (online only). Com-
pression is commonly provided with stockings; these stock-
ings are not covered by Medicare because they do not fall
into any Medicare statutorily defined benefit category.
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Many elderly patients have reduced strength and dexterity
that makes it difficult to put on the stockings.3-6 Compres-
sion may also be provided with an Unna’s boot or with
different types of elastic bandages. Some patients have
reported difficulty with these methods as well.7,8
Compression to the limb may be provided with pneu-
matic compression devices. Pneumatic compression devices
consist of an inflatable boot and a pneumatic pump that fills
the boot with compressed air. The boot is intermittently
inflated and deflated, with cycle times and pressures that
vary between devices. The boots may have a single chamber
that is inflated to a single pressure or multiple chambers
that are individually inflated in sequential order, to produce
a “milking” effect on the limb. The latter type of device may
have preset pressures in each chamber or pressures that are
individually set for each chamber. Individually controllable
pressures would allow patients to lower the pressure in
chambers directly over the site of an ulcer.
EVIDENCE MODEL
Figure 1 outlines an evidence model for the action of
pneumatic compression pumps. In this model, pneumatic
pumps affect the physiologic processes underlying CVI and
venous ulcers, leading to beneficial health outcomes such as
reduced edema, prevention of lymphedema, and increased
rates of ulcer healing. Pneumatic compression may also lead
to adverse events. In this assessment, we searched for data
on the use of pneumatic compression in the home environ-
ment for patients with venous insufficiency of the lower
extremities or leg ulcers from CVI. Studies on patients with
lymphedema were excluded because pneumatic compres-
sion devices for lymphedema were the subject of a separate
Medicare coverage decision.
Many studies investigate the effect of pneumatic com-
pression on intermediate outcomes on the basis of assump-
tions about the underlying physiology of CVI and venous
ulcers. However, these physiologic processes are poorly
understood.9 One theory of the action of pneumatic com-
pression is that use of the device increases oxygen tension.
Studies have shown that venous ulcers, like other wounds,
have low oxygen tension and that wounds associated with
an oxygen tension of less than 20 mm Hg are unable to
heal.10,11 Some researchers have found that intermittent
pneumatic compression increases oxygen tension in venous
ulcers,12 and others found no difference in oxygen tension
with pneumatic compression.11 Another theory is that
pneumatic compression increases blood flow (measured
with the clearance of small-molecular weight radiolabeled
markers or a laser Doppler fluxmeter) and/or lymphatic
clearance (measured with the clearance of large-molecular
weight radiolabeled markers) at the site of the ulcer. How-
ever, different studies found conflicting results on the clear-
ance of large and small molecules with the use of pneumatic
compression.13-15 Differences between studies may be ex-
plained by different protocols of pneumatic compression,
different methods of measurement, and different patient
populations. More research is needed in this area.
Many studies have measured the effects of different
cycle times, pressures, and multichamber versus single-
chamber devices on physiologic measurements on healthy
volunteers and patients (reviewed by Allsup16). These stud-
ies found that the use of multichamber devices and higher
pressures led to greater increases in venous blood flow than
single-chamber devices and lower pressures, respectively.
However, one study found no additional increases in blood
velocity at pressures above 35 mm Hg at the ankle, and
another study found that blood velocity continued to in-
crease at pressures above 55 mm Hg at the ankle. Compres-
sion with single-chamber devices led to trapping of venous
blood in the distal veins, whereas sequential gradient com-
pression results in more complete emptying of the deep
veins.17 Venous system refilling time was approximately 45
seconds in two different studies, which led to a recommen-
dation of a cycle time of approximately 70 seconds to allow
the venous system to refill while the devices were deflat-
ed.16 Many of these studies were done on healthy volun-
teers or a population with the devices to prevent deep vein
thrombosis, which led to questions of the applicability of
these results to a patient population with CVI. In addition,
the poor understanding of the physiologic processes under-
lying CVI and the mechanism of action of the devices
makes interpretation of these studies difficult.
Reporting of adverse events is poor in many areas of
medical research,18 which results in insufficient knowledge
about the true spectrum and frequency of adverse events.
This is likely to be the case for pneumatic compression
devices as well. Peroneal neuropathy and compartment
syndrome, where circulation and function of tissues within
a closed space are compromised by increased pressure,
leaving muscles and nerves susceptible to injury, have been
reported with the use of pneumatic compression to prevent
deep vein thrombosis.19 Genital edema has been reported
when pneumatic compression devices are used for lower
limb lymphedema.20 Pneumatic compression is contraindi-
cated in patients with significant arterial insufficiency,
edema from congestive heart failure, active phlebitis, deep
vein thrombosis, or the presence of localized wound infec-
tion or cellulitis.21 These may be relative rather than abso-
lute contraindications. For example, arterial disease may be
a relative contraindication; compression with stockings or
bandages may be used in these patients at lower pres-
sures.22 Very high compression reduces blood supply to the
skin and may lead to pressure damage, and even moderate
pressures in patients with impaired blood supply to the legs
may result in pressure damage.23
METHODS
The systematic review was carried out by the Agency for
Healthcare Research and Quality (AHRQ) Technology
Assessment staff trained in systematic review methodology.
The technology assessment was reviewed by four content
experts before it was sent to CMS.
The questions and inclusion and exclusion criteria for
the systematic review were developed in collaboration with
staff from CMS. CMS was given the opportunity to review
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and comment on the draft manuscript at the same time the
draft was sent to external reviewers. The authors considered
the comments of CMS and the external reviewers and
modified the manuscript on the basis of the comments. The
content of the final report and decisions regarding publica-
tion in a peer-reviewed journal rested solely with the au-
thors.
Literature was searched in the medical databases MED-
LINE, EMBASE, and AMED (Allied and Complementary
Medicine) from the inception of the databases to March 8,
2001, with keywords related to pneumatic compression,
venous insuffiency, and venous ulcers. A full description of
the literature search is given in Appendix 2 (online only).
This search found 91 articles, seven of which contained
relevant clinical trials. Reference lists of review articles were
hand searched, but no additional articles were found. An
expert reviewer suggested an additional study that was
included in the review.
Data was extracted from the studies directly into an
evidence table (Table I, online only) by one assessor. A
second assessor verified the extracted data. The assessors
noted key attributes of each study that affect relevance and
validity in the comments column of the evidence table.
RESULTS
Results by study
Ginsberg et al24 studied the effect of pneumatic com-
pression in patients with CVI associated with severe post-
phlebitic syndrome. All patients were given pneumatic
pressure devices, and patients were randomized to either a
therapeutic pressure of 50 mm Hg or a placebo pressure of
15 mm Hg for 20-minute sessions twice daily. After 1
month, patients were crossed over to the alternate pressure.
Results were measured with a symptom questionnaire; on
this questionnaire, higher scores correspond to fewer symp-
toms, with a score of 70 for the least severely affected
patients. The mean symptom score increased from 14.4
with the placebo pressure to 16.5 (P  .007) with the
therapeutic pressure. The authors state that this difference
is clinically significant, but it is very small.
Arcelus and Caprini25 measured clinical improvement
in 18 patients aged 23 to 62 years with CVI. Compression
was provided with a sequential gradient device, 4 hours per
day, 35 to 50 mm Hg for 11 seconds, with 60 seconds
between cycles. Clinical improvement was measured with a
questionnaire about symptoms before and after the use of
the pump. Symptoms included swelling, discomfort, dis-
coloration of the skin, cosmetic problems, decreased activ-
ity tolerance, depression, sleep problems, and interference
with work. The study measured a significant decrease in the
scores, indicating a significant clinical improvement with
the use of the pump. Patients rated their pre-pump symp-
toms retrospectively after using the pump; answers on
retrospective questionnaires may be subject to recall bias.
Older patients rated the device as more inconvenient, sug-
gesting the potential for lower compliance.
Pflug26 measured the improvement in signs and symp-
toms of 252 patients with venous edema (188 mild; 64
severe) with the single-chamber device at least 3 hours
daily. No demographic information is given about these
patients, and no definition of “signs” or “symptoms” is
given. More than 90% of the patients had improvements of
signs and symptoms. Statistical significance was not measured.
Rowland27 measured the time to ulcer healing, change
in ulcer size, and change in lower limb volume. The study
was a crossover randomized controlled trial (RCT). Pa-
tients were switched to the alternative therapy after 2 to 3
months, depending on the rate of healing. Sixteen patients
were originally enrolled, and five patients withdrew from
the study after the first or second visit (three from the pump
group and two from the bandage group). Patients in the
pneumatic compression group received treatment with a
single-chamber device, 1 hour each morning and evening.
Control patients received high stretch bandaging. There
was no difference in intention-to-treat analysis of ulcer
healing rate and lower limb volume between the groups.
Patients reported that the device was easier to use and more
comfortable than the bandaging. Only three patients had
complete healing by the end of the study. The authors
comment that the power of the study may be too low to
detect a real difference.
Schuler et al28 studied the effect of a sequential gradi-
ent compression system compared with Unna’s boot in a
RCT of 54 patients ranging in age from 31 to 85 years.
Patients were instructed to use the pneumatic compression
devices for 1 hour in the morning and 2 hours in the
evening with their legs elevated (12 seconds of compres-
sion, 60-second interval, 50 mm Hg at the ankle). Patients
wore stockings between pumping sessions. There was no
significant difference in fraction of patients who achieved
complete healing in 6 months, average healing rates, or
pain scores.
Smith et al29 studied the effect of a sequential gradient
compression device used 4 hours per day in a RCT of 45
patients ranging in age from 42 to 78 years. Patients in the
experimental and control groups received compression
stockings (30 to 40 mm Hg compression at the ankle) and
were instructed to wear stockings during pumping sessions.
One of 24 patients had healing within 3 months in the
control group compared with 10 of 22 patients in the
pneumatic compression group (P  .009). The median
healing rate was 2.1% of ulcer area per week in the control
group compared with 19.8% of ulcer area per week in the
pneumatic compression group (P  .046). This was an
intention-to-treat analysis.
Mulder and Reis8 studied the effect of a sequential
gradient compression device in a historic control study on
10 patients with an average age of 68 years. Patients were
their own control; they entered the study after 42 days of
failed Unna’s boot therapy. Patients were instructed to use
the sequential compression devices for 1 hour each morn-
ing and 2 hours each evening. Two patients dropped out,
one for equipment failure and one for lack of compliance.
There was a significant decrease in wound area over time in
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patients remaining in the study (P  .01), with only one
patient with complete healing in 120 days. Mulder and
Reis8 report that patients were followed for 1 year after
study termination and that two patients who discontinued
pump use had recurrent wounds that healed after a return
to pump use.
Hazarika and Wright30 studied the effect of a single-
chamber device in a prospective controlled study of 21
patients with an age range from 50 to 82 years. No indica-
tion was given on how patients were chosen for treatment
or control. Patients used the device once daily for 2 to 3
hours at “comfortable” pressure settings (30 to 80 mm
Hg). Most control patients had no change or worsening of
ulcers; several pneumatic compression patients had im-
proved ulcers, and a few of those who reported low com-
pliance had ulcers that did not change or increased in size.
Statistical significance of the results was not reported.
Results by question
Following is a summary of results in response to specific
questions posed by CMS about the effectiveness of pneu-
matic compression pumps.
At what point in therapy should the pneumatic
compression devices be introduced? Three stud-
ies25,26,31 showed an improvement in signs and symptoms
of CVI with the use of pneumatic compression devices. No
studies were specifically designed to test whether use of the
devices could prevent ulcers. Two patients who discontin-
ued use of the compression device in one study8 had
recurrence of ulcers that healed when use of the device was
reinitiated. This is consistent with circumstantial evidence
from studies that compression with stockings and bandag-
ing systems prevents recurrence of venous ulcers.32
Most patients in the studies of ulcer healing had
chronic ulcers that had not healed for several months or
more. Therefore, no conclusions can be made about
whether pneumatic compression can improve rates of ulcer
healing in new ulcers compared with other therapies.
One RCT and two other studies8,29,30 found that
pneumatic compression devices increased rates of healing in
chronic ulcers that had not healed for several months or
more with other methods. Two other RCTs27,28 found no
difference compared with control methods. This may be
because of differences in treatment of control patients;
however, a previous review had found no difference in ulcer
healing rates among high compression methods, such as
stockings, bandages, and Unna’s boot. This may also be
because of differences in protocol (see question 2).
Overall, the results suggest that patients with CVI who
have not yet had ulcers develop may have a small benefit
from the use of pneumatic compression. No data exist on
patients with new ulcers, and data are mixed on whether
pneumatic compression pumps aid healing of chronic ul-
cers that have not responded to other therapies for several
months or longer.
What protocol should be used to maximize effec-
tiveness of the pneumatic compression devices? No
studies directly compared the effectiveness of single-cham-
ber devices with gradient multichamber devices. Both types
of devices had a beneficial effect compared with control
methods in some studies and no difference compared with
control methods in other studies. Several researchers have
made physiologic arguments favoring multichamber gradi-
ent devices. Results from different physiologic studies con-
flict, and more research is needed in this area.
Three of the studies8,28,29 on patients with ulcers used
sequential gradient multichamber devices; it was not spec-
ified whether these were the type with individual pressure
control in each chamber. Pressures and cycle times were
mostly set as recommended by the manufacturer. Recom-
mendations for these parameters are from physiologic stud-
ies. None of the studies directly compared the effects of
different pressures or cycle times on health outcomes, such
as ulcer healing rates. In most studies, patients were in-
structed to use the device for several hours each day.
Some studies replace other compression treatments
with pneumatic compression, and other studies use the
pneumatic compression device in conjunction with other
methods of compression. There are many other variables in
the studies. For example, one RCT by Schuler et al28 that
showed no additional benefit for the devices asked control
patients to sit for 3 hours daily with elevated legs. Another
RCT by Smith et al29 that showed a benefit of the devices
over the control methods only asked the control patients to
elevate legs while sitting with no specific time period men-
tioned. Smith et al29 comment that they cannot rule out
that some of the effect may be from pneumatic compression
patients sitting with elevated legs for longer periods. An-
other variable was how the stockings were worn. Patients
wore stockings in both studies; however, in the study by
Schuler et al,28 patients were asked to remove their stock-
ings during pumping sessions, and in the study by Smith et
al,29 patients wore stockings during pumping sessions.
Some studies not reviewed here had patients come to a
clinic to receive pneumatic compression sessions. For ex-
ample, McCulloch et al33 found that patients who received
an hour of pneumatic compression twice weekly had signif-
icantly improved rates of ulcer healing compared with
control patients.
Overall, there are no data that can be relied on to
develop a protocol to maximize the effectiveness of the
pneumatic compression pumps.
Are there absolute indications or contraindications
to use of pneumatic compression therapy? Indications
for the use of pneumatic compression that have been ad-
dressed in studies are CVI with edema and CVI with
chronic ulceration that had not healed in several months or
more with other treatments.
Few adverse events were reported in the clinical trials.
However, a few patients dropped out from several trials;
this may be because of adverse events. One patient in the
study of Schuler et al28 had cellulitis develop with the use of
a sequential gradient compression system. One study re-
ported that patients were generally able to use the devices at
home,26 but another study reported that some elderly
patients had a fear of the devices.30
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Pneumatic compression is contraindicated in patients
with significant arterial insufficiency, edema from conges-
tive heart failure, active phlebitis, deep vein thrombosis, or
the presence of localized wound infection or cellulitis.
These may be relative rather than absolute contraindica-
tions.
CONCLUSION
Compression therapy is an important part of treatment
for CVI and venous leg ulcers. Often patients do not
comply with compression therapies, such as stockings, ban-
dages, and Unna’s boot, because of difficulty with use of
the therapies.
Long-term use of pneumatic compression devices in
the home environment may be an alternative to other
compression therapies for patients who are unable or refuse
to comply with other methods. In addition, pneumatic
compression may be effective for patients who have previ-
ously failed treatment with other compression devices,
either in addition to, or instead of, these other methods.
Trials of pneumatic compression devices for the treatment
of CVI and venous leg ulcers include few patients and may
not have enough power to detect differences. Several stud-
ies have randomized designs with well-defined outcome
measures and results that reach statistical significance. The
results are mixed. There are many protocol differences
between studies, including choice of compression system
for control patients.
A previous review found no evidence of different effec-
tiveness for different types of compression, such as stock-
ings, bandages, or Unna’s boot.23 However, other vari-
ables, such as length of time spent with legs elevated or
whether stockings are worn during pumping sessions,
might affect results. Several studies did show significant
improvement with the use of pneumatic compression de-
vices of long-standing chronic ulcers that had not healed
with other methods. Few adverse events were recorded.
Some patients expressed fear of using the devices, but
patients who agreed to use the devices generally expressed
satisfaction and reported higher compliance than with
other compression methods.
This systematic review has several potential limitations.
The scope of the systematic review was narrowly defined by
the policy question asked by CMS. Therefore, the focus of
the systematic review was data directly studying the effec-
tiveness of pneumatic compression devices. However, a
more broadly defined systematic review that presents an
overview of care of patients with venous insufficiency and
venous ulcers, including assessment and a full range of
treatments, might be useful to clinical decision making.
Another potential limitation is the scope of the literature
review. We have tried to ensure that the literature search
had as little bias as possible by searching three different
electronic databases and searching for grey literature
through suggestions of experts and hand searches of refer-
ences in review articles. For practical reasons, we did ex-
clude articles in languages other than English. Ideally,
articles in all languages should be included. However,
researchers in other areas have found that 78% of identified
meta-analyses have language of publication restrictions and
that there is no evidence that language restricted meta-
analyses lead to biased estimates of intervention effective-
ness.34
CMS considered the results of this technology assess-
ment and decided not to change the coverage policy.
Pneumatic compression will only be covered for patients
with refractory edema with significant ulceration of the
lower extremities after a 6-month treatment with standard
methods, such as compression stockings, has failed.35
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